CHINARES PHARMA (03320) has successfully issued 1.1 billion yuan in corporate bonds.

CHINARES PHARMA (03320) announced that the first tranche of 2025 corporate bonds with a total principal amount of 1.1 billion yuan has been issued, with a term of three years and a coupon rate of 1.82% per annum. The net proceeds will be used for productive expenses, including repaying corporate debts, supplementing working capital, project development and operational expenses, investments related to technological innovation, and other purposes in compliance with applicable laws and regulations.